Halozyme Therapeutics, Inc. vs. Iovance Biotherapeutics, Inc. Common Stock
HALO
Halozyme Therapeutics, Inc.
$103.63 -15.72%
VS IOVAIovance Biotherapeutics, Inc. Common Stock
$8.04 +3.88%
Halozyme Therapeutics, Inc. and Iovance Biotherapeutics, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| HALO | IOVA | |
|---|---|---|
| Market Cap | $11.81 billion | $3.72 billion |
HALO leads on 1 of 1 size & scale factors.
Risk & Sentiment
| HALO | IOVA | |
|---|---|---|
| Short Interest | 9.79% | 0.81% |
IOVA leads on 1 of 1 risk & sentiment factors.
Dig deeper: HALO overview, HALO financials, IOVA overview, IOVA financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.